Ethics of early clinical trials in regenerative medicine in transplantation
| Bio-artificial organs and bio-engineered or bio-printed tissues for transplantation in humans are rapidly being developed. It is anticipated that some applications will be ready for clinical testing in the near future. How can first-in-human clinical trials be conducted in a safe and responsible manner? What are ethical points to consider for early clinical trials of regenerative medicine in transplantation? This workshop brings together experts in the fields of regenerative medicine and ethics to discuss these ethical challenges. | |
| KEYNOTE SPEAKER
|
Professor Jonathan Kimmelman, McGill University
Director of Biomedical Ethics Unit Author of Gene Transfer and the Ethics of First-in-Human Trials: Lost in Translation |
| SHOWCASES OF REGENERATIVE MEDICINE APPLICATIONS | Insights from 3 projects funded through EU Horizon 2020
‘Regenerative medicine: From new insights to new applications’ – VANGUARD: Dide de Jongh, Erasmus MC |
| PANEL DISCUSSION
|
Moderated by Eline Bunnik & Emma Massey, Erasmus MC
Panel members |
Register online, meeting is open to the public. Attendance is free. Registration is required.
